A citation-based method for searching scientific literature

Ahmed Elkamhawy, Ahmed H E Hassan, Sora Paik, Yong Sup Lee, Hwi-Ho Lee, Ji-Sun Shin, Kyung-Tae Lee, Eun Joo Roh. Bioorg Chem 2019
Times Cited: 20







List of co-cited articles
85 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-β modulators.
Ahmed Elkamhawy, Nam Youn Kim, Ahmed H E Hassan, Jung-Eun Park, Jeong-Eun Yang, Kwang-Seok Oh, Byung Ho Lee, Mi Young Lee, Kye Jung Shin, Kyung-Tae Lee,[...]. Eur J Med Chem 2018
18
38


Natural products hybrids: 3,5,4'-Trimethoxystilbene-5,6,7-trimethoxyflavone chimeric analogs as potential cytotoxic agents against diverse human cancer cells.
Ahmed H E Hassan, Eunwoo Choi, Yoon Mi Yoon, Kun Won Lee, Sung Yeun Yoo, Min Chang Cho, Ji Seul Yang, Hye In Kim, Joo Young Hong, Ji-Sun Shin,[...]. Eur J Med Chem 2019
22
25

Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders.
Ahmed Karam Farag, Ahmed Elkamhawy, Ashwini M Londhe, Kyung-Tae Lee, Ae Nim Pae, Eun Joo Roh. Eur J Med Chem 2017
21
25

Design, synthesis and evaluation of alkylphosphocholine-gefitinib conjugates as multitarget anticancer agents.
Md Maqusood Alam, Ahmed H E Hassan, Yeong Ho Kwon, Hyo Jong Lee, Nam Yong Kim, Kyung Hoon Min, Sang-Yoon Lee, Dong-Hyun Kim, Yong Sup Lee. Arch Pharm Res 2018
15
26

First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent.
Ahmed Karam Farag, Ahmed H E Hassan, Hyeanjeong Jeong, Youngji Kwon, Jin Gyu Choi, Myung Sook Oh, Ki Duk Park, Yun Kyung Kim, Eun Joo Roh. Eur J Med Chem 2019
17
23

Design, synthesis and cytotoxicity of chimeric erlotinib-alkylphospholipid hybrids.
Md Maqusood Alam, Ahmed H E Hassan, Kun Won Lee, Min Chang Cho, Ji Seul Yang, Jiho Song, Kyung Hoon Min, Jongki Hong, Dong-Hyun Kim, Yong Sup Lee. Bioorg Chem 2019
13
30


Repurposing mosloflavone/5,6,7-trimethoxyflavone-resveratrol hybrids: Discovery of novel p38-α MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators.
Ahmed H E Hassan, Sung Yeun Yoo, Kun Won Lee, Yoon Mi Yoon, Hye Won Ryu, Youngdo Jeong, Ji-Sun Shin, Shin-Young Kang, Seo-Yeon Kim, Hwi-Ho Lee,[...]. Eur J Med Chem 2019
17
23

Synthesis and in vitro screening of phenylbipyridinylpyrazole derivatives as potential antiproliferative agents.
Mohammad M Al-Sanea, Ahmed Elkamhawy, Ahmed Zakaria, Byung Sun Park, Youngjoo Kwon, So Ha Lee, Sang Woo Lee, In Tae Kim. Molecules 2015
11
36

Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents.
Seokmin Kang, Jung Moo Lee, Borami Jeon, Ahmed Elkamhawy, Sora Paik, Jinpyo Hong, Soo-Jin Oh, Sun Ha Paek, C Justin Lee, Ahmed H E Hassan,[...]. Eur J Med Chem 2018
18
16

Design, synthesis, biological evaluation and molecular modelling of 2-(2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2H)-ones: A novel class of TSPO ligands modulating amyloid-β-induced mPTP opening.
Ahmed Elkamhawy, Jung-Eun Park, Ahmed H E Hassan, Ae Nim Pae, Jiyoun Lee, Beoung-Geon Park, Sora Paik, Jimin Do, Jong-Hyun Park, Ki Duk Park,[...]. Eur J Pharm Sci 2017
18
16

An overview of molecular hybrids in drug discovery.
Gervais Bérubé. Expert Opin Drug Discov 2016
95
15

NF-κB signaling in inflammation.
Ting Liu, Lingyun Zhang, Donghyun Joo, Shao-Cong Sun. Signal Transduct Target Ther 2017
15

Recent advances in irreversible kinase inhibitors.
Adam M Gilbert. Pharm Pat Anal 2014
11
27

Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation.
Ahmed Elkamhawy, Nam Youn Kim, Ahmed H E Hassan, Jung-Eun Park, Jeong-Eun Yang, Mohamed H Elsherbeny, Sora Paik, Kwang-Seok Oh, Byung Ho Lee, Mi Young Lee,[...]. Bioorg Chem 2019
6
50

Targeting EGFR/HER2 tyrosine kinases with a new potent series of 6-substituted 4-anilinoquinazoline hybrids: Design, synthesis, kinase assay, cell-based assay, and molecular docking.
Ahmed Elkamhawy, Ahmed Karam Farag, Ambily Nath Indu Viswanath, Tarek M Bedair, Dong Gyu Leem, Kyung-Tae Lee, Ae Nim Pae, Eun Joo Roh. Bioorg Med Chem Lett 2015
25
15

Synthesis and evaluation of new pyridyl/pyrazinyl thiourea derivatives: Neuroprotection against amyloid-β-induced toxicity.
Jung-Eun Park, Ahmed Elkamhawy, Ahmed H E Hassan, Ae Nim Pae, Jiyoun Lee, Sora Paik, Beoung-Geon Park, Eun Joo Roh. Eur J Med Chem 2017
16
18

Epidermal growth factor receptor targeting in cancer.
John Mendelsohn, Jose Baselga. Semin Oncol 2006
516
15


EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo.
Chenfei Zhou, Liangjun Zhu, Jun Ji, Fangmi Ding, Chao Wang, Qu Cai, Yingyan Yu, Zhenggang Zhu, Jun Zhang. Curr Cancer Drug Targets 2017
8
37

Antiproliferative, antiangiogenic and proapoptotic activity of h-R3: A humanized anti-EGFR antibody.
Tania Crombet-Ramos, Janusz Rak, Rolando Pérez, Alicia Viloria-Petit. Int J Cancer 2002
129
15


An aberrant STAT pathway is central to COVID-19.
Toshifumi Matsuyama, Shawn P Kubli, Steven K Yoshinaga, Klaus Pfeffer, Tak W Mak. Cell Death Differ 2020
122
15

Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck.
Tania Crombet Ramos, Braulio Mestre Fernández, Zaima Mazorra Herrera, Normando E Iznaga Escobar. Front Oncol 2020
14
21

Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
Tania Crombet, Marta Osorio, Teresa Cruz, Carlos Roca, Ramón del Castillo, Rosa Mon, Normando Iznaga-Escobar, René Figueredo, James Koropatnick, Enrique Renginfo,[...]. J Clin Oncol 2004
234
15

IL-6 in inflammation, autoimmunity and cancer.
Toshio Hirano. Int Immunol 2021
122
15

NCATS launches drug repurposing program.
Malorye Allison. Nat Biotechnol 2012
71
10


4'-bromo-5,6,7-trimethoxyflavone represses lipopolysaccharide-induced iNOS and COX-2 expressions by suppressing the NF-κB signaling pathway in RAW 264.7 macrophages.
Dong Han Kim, Chang Hyeon Yun, Min Hwan Kim, Ch Naveen Kumar, Bo Hee Yun, Ji-Sun Shin, Hyo Jin An, Young Hun Lee, Yong Don Yun, Hong-Kun Rim,[...]. Bioorg Med Chem Lett 2012
15
13

Drug repositioning: identifying and developing new uses for existing drugs.
Ted T Ashburn, Karl B Thor. Nat Rev Drug Discov 2004
10

Prostaglandins and inflammation.
Emanuela Ricciotti, Garret A FitzGerald. Arterioscler Thromb Vasc Biol 2011
10

Flavones: an important scaffold for medicinal chemistry.
Manjinder Singh, Maninder Kaur, Om Silakari. Eur J Med Chem 2014
202
10

Covalent inhibitors design and discovery.
Stephane De Cesco, Jerry Kurian, Caroline Dufresne, Anthony K Mittermaier, Nicolas Moitessier. Eur J Med Chem 2017
137
10

Inhibitors of NF-kappaB signaling: 785 and counting.
T D Gilmore, M Herscovitch. Oncogene 2006
434
10


Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
Subash C Gupta, Chitra Sundaram, Simone Reuter, Bharat B Aggarwal. Biochim Biophys Acta 2010
527
10

Developing irreversible inhibitors of the protein kinase cysteinome.
Qingsong Liu, Yogesh Sabnis, Zheng Zhao, Tinghu Zhang, Sara J Buhrlage, Lyn H Jones, Nathanael S Gray. Chem Biol 2013
410
10

Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions.
R Scott Obach, Robert L Walsky, Karthik Venkatakrishnan. Drug Metab Dispos 2007
333
10

Targeting IKK and NF-κB for Therapy.
J K Durand, A S Baldwin. Adv Protein Chem Struct Biol 2017
61
10

Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine.
Ting Dong, Chao Li, Xing Wang, Longyang Dian, Xiuguo Zhang, Lin Li, She Chen, Ran Cao, Li Li, Niu Huang,[...]. Nat Commun 2015
60
10


Recent advances in the structure-based and ligand-based design of IKKβ inhibitors as anti-inflammation and anti-cancer agents.
Jing-Jie Huang, Hong-Xi Chu, Zheng-Yu Jiang, Xiao-Jin Zhang, Hao-Peng Sun, Qi-Dong You. Curr Med Chem 2014
13
15


Isoliquiritigenin suppresses human T Lymphocyte activation via covalently binding cysteine 46 of IκB kinase.
Fenggen Yan, Fen Yang, Rui Wang, Xiao Jun Yao, Liping Bai, Xing Zeng, JiaJun Huang, Vincent Kam Wai Wong, Christopher Wai Kei Lam, Hua Zhou,[...]. Oncotarget 2017
7
28

The IKK NF-kappa B system: a treasure trove for drug development.
Michael Karin, Yumi Yamamoto, Q May Wang. Nat Rev Drug Discov 2004
10

Crystal structure of inhibitor of κB kinase β.
Guozhou Xu, Yu-Chih Lo, Qiubai Li, Gennaro Napolitano, Xuefeng Wu, Xuliang Jiang, Michel Dreano, Michael Karin, Hao Wu. Nature 2011
140
10



Inhibitory kappa B Kinases as targets for pharmacological regulation.
Carly Gamble, Kathryn McIntosh, Rebecca Scott, Ka Ho Ho, Robin Plevin, Andrew Paul. Br J Pharmacol 2012
81
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.